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rowth regulation of epithelial cells is of major
concern because most human cancers arise from
them. We demonstrated previously a novel sig-
nal pathway involving S100C/A11 for high Ca
 
2
 
 
 
-induced
growth inhibition of normal human keratinocytes (Sakaguchi,
M., M. Miyazaki, M. Takaishi, Y. Sakaguchi, E. Makino, N.
Kataoka, H. Yamada, M. Namba, and N.H. Huh. 2003.
 
 
 
J.
Cell Biol.
 
 163:825–835). This paper addresses a question
whether transforming growth factor 
 
 
 
 (TGF
 
 
 
) shares the
pathway with high Ca
 
2
 
 
 
. On exposure of the cells to TGF
 
 
 
1,
S100C/A11 was phosphorylated, bound to nucleolin,
G
 
and transferred to the nucleus, resulting in induction of
p21
 
WAF1/CIP1
 
 and p15
 
INK4B
 
 through activation of Sp1. Protein
kinase C 
 
 
 
 (PKC
 
 
 
) was shown to phosphorylate 
 
10
 
Thr of
S100C/A11, which is a critical event for the signal trans-
duction. The TGF
 
 
 
1-induced growth inhibition was almost
completely mitigated when PKC
 
 
 
 activity was blocked or
when S100C/A11 was functionally sequestered. These results
indicate that, in addition to the well-characterized Smad-
mediated pathway, the PKC
 
 
 
–S100C/A11-mediated pathway
is involved in and essential for the growth inhibition of
normal human keratinocytes cells by TGF
 
 
 
1.
 
Introduction
 
Transforming growth factor 
 
 
 
 (TGF
 
 
 
) is a representative
growth inhibitor for many kinds of epithelial cells (Moses et
al., 1990, 1991). The signal triggered by TGF
 
 
 
 on the cell
surface is transduced to the nucleus by a pathway involving
Smads (Heldin et al., 1997; Moustakas et al., 2002; Fig. 5).
The TGF
 
 
 
 receptor activated by the ligand binding phos-
phorylates receptor-restricted Smad2 and Smad3, and the
activated Smads dimerize with a co-Smad4 and are translo-
cated to nuclei where they exert their growth inhibitory effect
by transcriptional activation of Cdk inhibitors, p21
 
WAF1/CIP1
 
and p15
 
INK4B
 
, and suppression of c-myc (Massague et al.,
2000). For the transcriptional regulation, interaction of Smads
with a number of different transacting factors, including Sp1
in particular, is needed (Feng et al., 2000). When the intracel-
lular signal transduction for TGF
 
 
 
 is impaired, epithelial cells
undergo aberrant growth and eventually acquire malignant
phenotypes (Massague et al., 2000; Pasche, 2001). Thus,
mutation in the type II TGF
 
 
 
1 receptor was frequently
observed in hereditary nonpolypotic colon cancer (Markowitz
et al., 1995). Smad4 was first cloned as a tumor suppressor
gene for human pancreatic cancer and was shown to be deleted
in 50% of pancreatic cancer cases and 30% of colon cancer
cases with high malignancy (Riggins et al., 1997). In addition
to the Smad pathway, a number of cytoplasmic protein
kinases, including PKC and MAPKs, have been shown to be
involved in TGF
 
 
 
 signaling for induction of certain genes
(Hanafusa et al., 1999; Ignotz and Honeyman, 2000; Lai
and Cheng, 2002; Rosado et al., 2002; Edlund et al., 2003;
Yang et al., 2003).
Recently, we found that Ca
 
2
 
 
 
-induced growth inhibition
of normal human keratinocytes (NHKs) is mediated by
S100C/A11, a Ca
 
2
 
 
 
-binding protein with an EF-hand domain
(Sakaguchi et al., 2003; Fig. 5). On exposure of the cells to
high Ca
 
2
 
 
 
, cytoplasmic S100C/A11 protein was specifically
phosphorylated, bound to nucleolin, and transferred to nuclei.
In the nuclei, S100C/A11 liberated Sp1/3 from nucleolin,
and the resulting free Sp1/3 transcriptionally activated
p21
 
WAF1/CIP1
 
, a negative regulator of cell cycle progression.
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TGF
 
 
 
 is another representative growth inhibitor for NHK
cells. Therefore, we examined whether the S100C/A11 path-
way plays any role in TGF
 
 
 
 signaling and which protein ki-
nases are responsible for phosphorylation of S100C/A11.
 
Results and discussion
 
TGF
 
 
 
1 inhibits the growth of NHK cells by inducing 
p21
 
WAF1/CIP1
 
 via S100C/A11
 
First, we confirmed the inhibitory action of TGF
 
 
 
1 on
growth of NHK cells (Fig. 1 a). TGF
 
 
 
1 dose-dependently
inhibited incorporation of [
 
3
 
H]thymidine into an insoluble
fraction like high Ca
 
2
 
 
 
 (Fig. 1 a), concomitantly inducing
p21
 
WAF1/CIP1
 
 mRNA and protein (Fig. 1, b and c). Although
protein levels of Sp1 (which is known to play a key role with
Smads in inducing p21
 
WAF1/CIP1
 
) remained unchanged (Fig.
1 c), amounts of activated Sp1 that could bind to a GC-rich
region of the p21
 
WAF1/CIP1
 
 promoter were time-dependently
enhanced by TGF
 
 
 
1 as demonstrated using the chromatin
immunoprecipitation method (Fig. 1 d).
Nuclear translocation of S100C/A11, a hallmark of the
involvement of the S100C/A11 pathway (Sakaguchi et al.,
2003), was observed in NHK cells treated with TGF
 
 
 
1
even at a low dose of 1.0 ng/ml as was observed in cells ex-
posed to high Ca
 
2
 
 
 
 (Fig. 1 e). The nuclear translocation
of S100C/A11 was confirmed by subfractionation of the
cells (Fig. 1 f). When nucleolin was depleted with siRNA,
the nuclear translocation of S100C/A11 was completely
blocked (Fig. 1 f). TGF
 
 
 
1 induced phosphorylation of
S100C/A11 in a time-dependent manner (Fig. 1 g). Nucle-
olin was coprecipitated with the phosphorylated S100C/
A11. In the cells depleted of nucleolin, S100C/A11 re-
mained in the cytoplasm despite the fact that phosphoryla-
tion of S100C/A11 by TGF
 
 
 
1 took place normally (Fig. 1
h). We demonstrated previously that high Ca
 
2
 
 
 
-induced
phosphorylation of S100C/A11 at 
 
10
 
Thr and 
 
94
 
Ser in hu-
man keratinocytes and that only 
 
10
 
Thr-phosphorylation is
relevant to the binding to nucleolin, nuclear translocation,
and eventual growth inhibition (Sakaguchi et al., 2003). A
transfection experiment using S100C/A11 expression con-
structs with mutation at either or both phosphorylation
sites demonstrated that the same two sites as those phos-
phorylated by high Ca
 
2
 
 
 
 were phosphorylated by TGF
 
 
 
1
(Fig. 1 i). These results indicate that the S100C/A11-medi-
ated p21
 
WAF1/CIP1
 
-inducing pathway is activated by TGF
 
 
 
1
in a manner similar to that by high Ca
 
2
 
 
 
.
Figure 1. TGF 1 inhibits growth of NHKs by inducing 
p21
WAF1/CIP1 via S100C/A11. (a) Inhibition of [
3H]TdR 
incorporation in NHK cells treated with Ca
2  (left) or 
TGF 1 (right) for 6 h. Standard errors among three 
wells. (b) Dose-dependent induction of p21
WAF1/CIP1 
and S100C/A11 mRNA by TGF 1 (6 h) as assayed by 
Northern blot analysis. (c) Induction of p21
WAF1/CIP1 
protein, but not Sp1 protein, by 1 ng/ml of TGF 1. 
(d) 1 ng/ml of TGF 1 enhanced the binding of Sp1 to 
a GC-rich region in the p21
WAF1/CIP1 promoter as deter-
mined by chromatin immunoprecipitation. (e) Immuno-
staining for S100C/A11 of NHK cells treated with Ca
2  
or TGF 1. Bars, 20  m. (f) Depletion of nucleolin by 
0.2  M of siRNA (48 h before harvest) inhibits the 
nuclear translocation of S100C/A11 by TGF 1 (6 h 
before harvest). Wh, whole cell extract; Cyt, cytoplasmic 
fraction; Nuc, nuclear fraction. Tubulin and PCNA were 
used as markers for cytoplasmic and nuclear fractions, 
respectively. (g) [
32P]Phosphate-labeled NHK cells 
treated with TGF 1 were immunoprecipitated with 
anti-S100C/A11 antibody and immunoblotted with 
indicated antibodies or analyzed by autoradiography. 
(h) Cells were processed and analyzed as in panels f 
and g. (i) NHK cells were transfected with various 
GFP-tagged expression constructs of S100C/A11 
harboring mutations at the phosphorylation sites 42 h 
before harvest. The cells were labeled with [
32P]phos-
phate for 10 h and treated with TGF 1 for 6 h before 
harvest and then analyzed as in panel g. Wt, wild type; 
10TA, 
10Thr was replaced with Ala; 94SA, 
94Ser was 
replaced with Ala; 10/94, 
10Thr and 
94Ser were replaced 
with Ala. 
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PKC
 
 
 
 mediates the growth inhibitory signal triggered by 
TGF
 
 
 
1 and Ca
 
2
 
 
 
 by phosphorylating S100C/A11 at 
 
10
 
Thr
 
Next, we performed an experiment to determine which pro-
tein kinases phosphorylates S100C/A11 in NHK cells ex-
posed to TGF
 
 
 
1. When the cells were pretreated with various
protein kinase inhibitors, the general protein kinase inhibitor
H9 and the classical PKC inhibitor cPKCI, but not a MAPK
inhibitor (PD98059) or protein kinase A inhibitor, reduced
the TGF
 
 
 
1-induced phosphorylation level of S100C/A11
(Fig. 2 a). Activity to phosphorylate S100C/A11 in vitro in
cell extracts was recovered in fractions eluted from an anion-
exchange column with 160–180 mM KCl, in which most
PKC species were detected by Western blot analysis (unpub-
lished data). These results prompted us to examine possible
phosphorylation of S100C/A11 by PKCs. Among the dozen
known PKC species, classical PKC
 
 
 
, novel PKC
 
 
 
, PKC
 
 
 
,
PKC
 
 
 
, and atypical PKC
 
 
 
 are expressed in skin (Reynolds et
al., 1994). When recombinant proteins of these PKCs were
incubated with S100C/A11 in vitro, PKC
 
 
 
, PKC
 
 
 
, and
PKC
 
 
 
 significantly phosphorylated S100C/A11 in an activa-
tor-dependent manner (Fig. 2 b). PKC
 
 
 
 showed very weak
activity and PKC  did not phosphorylate to any appreciable
extent. To examine possible phosphorylation of S100C/A11
by PKCs in cells, PKC , PKC , PKC , PKC , and PKC 
were expressed in NHK cells using an adenovirus vector. Pro-
tein levels of PKCs in the transduced cells were 6.5–19-fold
higher than those in untreated cells. S100C/A11 was phos-
phorylated to an appreciable level only in PKC -transduced
cells in the absence of exogenous stimulation, and the phos-
phorylation facilitated the association of S100C/A11 to nucle-
olin (Fig. 2 c). On exposure of the PKC-transduced cells to
TGF 1, S100C/A11 was strongly phosphorylated in the cells
transfected with PKC , but all of the other cells showed re-
sponsiveness to TGF 1 similar to that of the control cells
transduced with lacZ. Activation of endogenous PKC  by
TGF 1 and high Ca
2  was demonstrated by detecting auto-
phosphorylation of PKC  (Fig. 2 d) and by translocation of
cytosolic PKC  to the plasma membrane (Fig. 2 e). 12-O-tet-
radecanoylphorbol-13-acetate, an activator of classical and
novel PKCs, was used as a positive control.
Using the S100C/A11 expression constructs mutated at
the phosphorylation sites, exogenous PKC  was shown to
phosphorylate 
10Thr but not 
94Ser (Fig. 3 a). It should be
noted that phosphorylation of 
10Thr, but not 
94Ser, is critical
for the binding to nucleolin and eventual nuclear transloca-
tion (Sakaguchi et al., 2003). Under the same conditions,
exogenous PKC  and PKC  phosphorylated neither 
10Thr
nor 
94Ser (unpublished data). When NHK cells were trans-
fected with the S100C/A11 constructs and exposed to
TGF 1, both 
10Thr and 
94Ser were phosphorylated (Fig. 1 i
and Fig. 3 b). Inhibition of PKC , the only cPKC expressed
in NHK cells, resulted in the blocking of phosphorylation of
10Thr but not 
94Ser (Fig. 3 b). Similar results were obtained
when the cells were stimulated with 1.5 mM Ca
2  (Fig. 3 c).
To confirm the specificity of PKC  further, we transduced a
dominant-negative form of PKC  (DN-PKC ) into NHK
cells. This DN-PKC  was prepared by replacing 
369Lys with
Arg and shown to specifically inhibit PKC  activity in cells
as well as in vitro (Ohno et al., 1990; Garcia-Bermejo et al.,
2002). As shown in Fig. 3 d, phosphorylation of 
10Thr in
S100C/A11 was specifically and completely blocked by
DN-PKC  in NHK cells exposed to TGF 1 or high Ca
2 .
Phosphorylation of S100C/A11 by PKC  and autophos-
phorylation of PKC  induced by TGF 1 do not need de
novo protein synthesis (Figs. S1 and S2, available at http://
www.jcb.org/cgi/content/full/jcb.200312041/DC1). These
results indicate that PKC  is the sole and specific kinase for
10Thr of S100C/A11 in response to TGF 1 or high Ca
2  in
NHK cells. At present, the precise mechanism of PKC  ac-
tivation is not clear. However, Ca
2  itself is an activator of
cPKCs, and the amount of diacylglycerol, another activator
for PKCs, was shown to increase in cells exposed to TGF 1
(Ignotz and Honeyman, 2000). Chakrabarty et al. (1998)
showed that down-regulation of PKC  blocked adhesion re-
sponse of human colon carcinoma cells to TGF 1.
Relevance of the S100C/A11-mediated pathway to 
TGF 1-induced growth inhibition
We examined whether activation of Sp1 through the S100C/
A11-mediated pathway was necessary at all for the growth in-
hibition induced by TGF 1. To address this issue, we either
Figure 2. Phosphorylation of S100C/A11 by PKC . (a) NHK cells 
pretreated (1 h before addition of TGF 1) with various protein kinase 
inhibitors (100  M each) were incubated with TGF 1 for 6 h and 
analyzed by immunoblotting or autoradiography with or without 
immunoprecipitation. H-9, N-(2-aminoethyl)-5-isoquinoline-
sulfonamide dihydrochloride; cPKCI, myristoylated PKC inhibitor; 
MAPKI, PD98059; PKAI, cAMP-dependent kinase peptide inhibitor. 
(b) Recombinant PKCs were incubated with S100C/A11 or myelin 
basic protein (MBP) in vitro in the presence or absence of activators 
(PS, phosphatidylserine; TPA, tetradecanoyl phorboracetate). (c) NHK 
cells were transduced with various PKCs using an adenovirus vector 
(10 multiplicity of infection, 48 h in advance), treated with 1 ng/ml 
of TGF 1 (6 h), and analyzed as in panel a. (d) Autophosphorylation 
of PKC  in NHK cells treated with 1 ng/ml of TGF 1, 1.5 mM of 
Ca
2 , or 100 nM of TPA for 1 h. (e) Translocation of PKC  from the 
cytoplasm to the plasma membrane in NHK cells treated as in panel d. 
Bars, 20  m.982 The Journal of Cell Biology | Volume 164, Number 7, 2004
inactivated PKC  using DN-PKC  or an inhibitor or func-
tionally depleted S100C/A11 by introducing a specific anti-
S100C/A11 antibody into the cells. As shown in Fig. 3 e,
TGF 1 suppressed DNA synthesis to 27% of the control
level, and the inhibition of PKC  activity by the dominant-
negative construct and cPKC inhibitor resulted in recovery of
DNA synthesis to 93% and 86% of the control level, respec-
tively. We demonstrated previously that anti-S100C/A11 an-
tibody blocked phosphorylation and nuclear translocation of
S100C/A11 when introduced into cells (Sakaguchi et al.,
2003). Under similar conditions, DNA synthesis was recov-
ered to 85% of the control level by the antibody, whereas IgG
showed no effect (Fig. 3 e). The mitigation of TGF 1-
induced growth inhibition was dependent on doses of the in-
hibitor and the antibody (unpublished data). p21
WAF1/CIP1 was
not induced in the presence of cPKCI or anti-S100C/A11 an-
tibody in TGF 1-treated cells (Fig. 3 f). Amount of Sp1
bound to a GC-rich region of the p21
WAF1/CIP1 promoter was
reduced by blocking PKC  or S100C/A11 as demonstrated
using the chromatin immunoprecipitation method (Fig. 3 g).
These results clearly show that the activation of Sp1 in terms
of enhanced binding to the p21
WAF1/CIP1 promoter through
the S100C/A11-mediated pathway is critically relevant to the
inhibition of growth of NHK cells by TGF 1.
Figure 3. Involvement of PKC  in phosphorylation of 
S100C/A11 at 
10Thr in NHK cells treated with TGF 1 or 
Ca
2  and relevance of the S100C/A11 pathway to TGF 1-
induced growth inhibition. (a) NHK cells transduced with 
various mutant S100C/A11 constructs (Fig. 1 i) in advance 
were infected with the adenovirus vectors and analyzed as 
in Fig. 2 c. (b) NHK cells transduced with various mutant 
S100C/A11 constructs 36 h in advance were treated with 
1 ng/ml of TGF 1 for 6 h before harvest. [
32P]Phosphate and 
the inhibitors were added 4 h and 1 h before the addition of 
TGF 1, respectively. The cells were analyzed as in Fig. 2 c. 
(c) NHK cells were exposed for 1.5 mM Ca
2  for 6 h and 
analyzed under conditions similar to those in panel b. (d) This 
experiment was performed under the same conditions as 
those in panel c except for additional infection with the 
adenovirus constructs 1 h after transfection of the S100C/A11 
constructs. (e) Mitigation of TGF 1-induced inhibition of 
DNA synthesis of NHK cells by either inhibiting PKC  or 
blocking S100C/A11. Adenovirus vectors carrying lacZ (lacZ) 
or dominant-negative PKC  (DN) were infected at 10 multi-
plicity of infection cPKCI, 100  M of myristoylated PKC 
inhibitor. Anti-S100C/A11 antibody or IgG was introduced 
into the cells by conjugating with PEI. Standard error among 
three wells. (f) Under conditions similar to those in panel e, 
cPKCI and anti-S100C/A11 antibody inhibited the induction 
of p21
WAF1/CIP1 protein by TGF 1. (g) Amount of Sp1 bound to the p21
WAF1/CIP1 promoter was determined by chromatin immunoprecipitation 
assay (top) using the cells treated under the same conditions as those in panel e. Sp1 protein level remained unchanged (bottom).
Figure 4. Involvement of Smad3 in TGF 1-
induced growth inhibition. (a) Mitigation of 
TGF 1-induced, but not high Ca
2 -induced, 
growth inhibition of NHK cells by down-
regulation of Smad3. The cells were treated 
with 0.2  M of siRNA and PEI-conjugated 
anti-S100C/A11 antibody 48 h and 1 h 
before, respectively, to the exposure to 
1 ng/ml of TGF 1 or 1.5 mM Ca
2 . Ct, 
control; GA, siRNA against GAPDH; Sm3, 
siRNA against Smad3; Ab, PEI-conjugated 
anti-S100C/A11 antibody. Standard error 
among three wells. (b) NHK cells were treated 
with various agents under conditions similar 
to those in panel a and analyzed by Western 
blotting. SC, antibody against S100C/A11. 
For other abbreviations, see panel a. (c–e) 
After treating NHK cells with the various 
agents under conditions similar to those in 
panel a, cell lysates (150  g of protein) were 
immunoprecipitated with respective anti-
bodies and the precipitates and supernatants 
that were condensed using acetone were 
simultaneously analyzed. C, control; TGF, 
TGF 1 1 ng/ml; Ca, Ca
2  1.5 mM.S100C/A11-mediated signaling for TGF  | Sakaguchi et al. 983
Smad-mediated pathway is also necessary for
TGF 1-induced growth inhibition
When NHK cells were exposed to siRNA against Smad3,
the protein level was efficiently down-regulated within 48 h
(Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200312041/DC1). Reduced [
3H]TdR incorporation by
TGF 1 (23% of the control level) was substantially miti-
gated to 63% of the control level by the down-regulation of
Smad3 (Fig. 4 a). The extent was comparable to that by
blocking S100C/A11 with an antibody (73%). This profile
of DNA synthesis was correlated well with the extent of in-
duction of p21
WAF1/CIP1 and p15
INK4B (Fig. 4 b). As expected,
high Ca
2 -induced growth inhibition does not appear to in-
volve Smad3. These results indicate that the Smad-mediated
pathway as well as the S100C/A11-mediated pathway is
needed for transduction of the TGF 1-triggered growth-
inhibitory signal. The down-regulation of Smad3 did not af-
fect binding of S100C/A11 to and release of Sp1 from nu-
cleolin (Fig. 4, c and e).
Signal transduction for TGF 1- and high Ca
2 -induced 
growth inhibition
Epidermal keratinocytes are one of the most frequently used
cells for studying molecular mechanisms of growth regula-
tion in epithelial cells. High Ca
2  and TGF  are well-
known representative growth inhibitors for NHK cells, but
intracellular signaling pathways for the agents remains sur-
prisingly unclear. A number of distinct but mutually inter-
acting pathways may function involving Ca
2 -dependent
proteins, protein kinases, Smads, and other transacting fac-
tors (Heldin et al., 1997; Feng et al., 2000; Santini et al.,
2001; Moustakas et al., 2002). This paper, in combination
with our previous one (Sakaguchi et al., 2003), clearly illus-
trates that the S100C/A11-mediated pathway is not only in-
volved in but also essential for the inhibition of growth of
NHK cells by high Ca
2  and TGF 1 (Fig. 5). The evidence
presented here unequivocally demonstrates that PKC  is the
sole kinase to phosphorylate 
10Thr of S100C/A11 in NHK
cells in response to TGF 1 and high Ca
2 . Consistent with
this, PKC  was recently shown to play a necessary role in
mediating Ca
2 -induced differentiation of NHK cells (Yang
et al., 2003). Furthermore, Tibudan et al. (2002) demon-
strated that PKC  was activated during suspension-induced
irreversible cell cycle withdrawal in human keratinocytes
with concomitant induction of p21
WAF1/CIP1.
In recent years, great progress has been made in the un-
derstanding of signal transduction for TGF  at molecular
levels, revealing the Smad-mediated pathway in particular.
There is increasing concern, however, as to whether the
Smad pathway is solely responsible for the entire effect of
TGF . This paper clearly shows that there is a distinct sig-
naling pathway involving PKC  and S100C/A11 that leads
to activation of Sp1, a key partner of activated Smads for
inducing p21
WAF1/CIP1 (Fig. 5). Sp1 has long been consid-
ered to be a ubiquitous transacting factor. It is true in the
sense that Sp1 is involved in transcriptional regulation of
diverse genes interacting many different proteins, but it
may not be true in the sense that it is functionally available
whenever needed. Sp1 protein was present at similar levels
in NHK cells before and after stimulation with TGF 1
(Fig. 1 c) but bound to the p21
WAF1/CIP1 promoter only after
treatment with TGF 1 (Fig. 1 d and Fig. 3 g). The results
of this paper may provide a clue for further study to under-
stand complex functional interactions among critical pro-
teins in nuclei.
Materials and methods
Cells and chemicals
NHK cells (KURABO) were cultured in defined keratinocyte-SFM (GIBCO
BRL) with defined keratinocyte-SFM growth supplement (GIBCO BRL). For
monitoring DNA synthesis, 1  Ci/ml of tritiated thymidine (American Ra-
diolabeled Chemicals) was added to the cultures 1 h before cell harvest.
Subfractionation of cells was performed as described previously (Linde-
man et al., 1997). TGF 1 and H9 (N-[2-aminoethyl]-5-isoquinoline-
sulfonamide dihydrochloride) were purchased from Sigma-Aldrich and
BIOMOL Research Laboratories, Inc., respectively. A myristoylated PKC
inhibitor (Eichholtz et al., 1993), cAMP-dependent kinase peptide inhibi-
tor, and PD98059 (2’-amino-3 -methocyflavone; English et al., 1999) were
purchased from Promega.
Gel electrophoresis and immunological analyses
Gel electrophoresis, Western blot analysis, and immunoprecipitation were
performed under conventional conditions. The antibodies used for West-
ern blot analysis were mouse anti–human nucleolin antibody (Molecu-
lar and Biological Laboratories), rabbit anti–human Sp1 antibody (Santa
Cruz Biotechnology), mouse anti–human p21
WAF1/CIP1 antibody (BD Bio-
sciences), mouse anti–human tubulin antibody (Sigma-Aldrich), mouse
anti–human PCNA antibody (BD Biosciences), and mouse anti-GFP anti-
body (Sigma-Aldrich). Polyclonal rabbit anti–human S100C antibody was
prepared in our laboratory (Sakaguchi et al., 2000). For immunoprecipita-
tion, rabbit anti–human S100C antibody, rabbit anti-GFP antibody (Molec-
ular and Biological Laboratories), and rabbit anti–human Sp1 antibody
(Upstate Biotechnology) were used.
Plasmid and adenovirus constructs
Plasmid expression constructs prepared as described previously (Sakagu-
chi et al., 2003) were transfected using Trans IT-keratinocyte transfection
reagent (Mirus). Preparation and characteristics of adenovirus constructs of
PKCs, and preparation of recombinant PKCs and in vitro kinase assay were
described previously (Ohba et al., 1998). Dominant-negative PKC  was
designed according to Ohno et al. (1990) and the nature of the construct
was confirmed in cells (Garcia-Bermejo et al., 2002).
siRNA
Synthesis of siRNAs against nucleolin and GAPDH was described previ-
ously (Sakaguchi et al., 2003). siRNA against Smad3 (5 -aacgtcaacaccaagt-
gcatc-3 ) was produced by in vitro transcription using the Silencer siRNA
Figure 5. Signaling pathways for high Ca
2 - and TGF 1-induced 
growth inhibition in NHK cells. Blue arrows, known from the results 
of studies by others; black arrows, revealed by our previous paper 
(Sakaguchi et al., 2003); red arrows, demonstrated in the present 
experiment.984 The Journal of Cell Biology | Volume 164, Number 7, 2004
construction kit (Ambion Inc.). The siRNAs were transfected to logarithmi-
cally growing NHK cells using Lipofectamine 2000 (Invitrogen).
Introduction of proteins into cells
Cationic polyethylenimine (PEI)-conjugated S100C antibody was used to
introduce antibodies into NHK cells.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed according to the method of
Takahashi et al. (2000). In brief, NHK cells were treated with 1% formalde-
hyde for cross-linking and immunoprecipitated with a rabbit pAb against
Sp1 (Santa Cruz Biotechnology). The primers used were those corresponding
to positions  328 to  309 and  56 to  37 of the p21
WAF1/CIP1 promoter.
Acquisition and processing of images
To acquire images of cells labeled with TRITC or FITC, a laser-scanning
microscope (Axioplan 2; objective lens, Plan-Apochromat 63  1.4 oil DC
and Plan-Neofluar 40 /0.75; Carl Zeiss MicroImaging, Inc.) was used.
Online supplemental material
Fig. S1 shows the effect of cycloheximide on phosphorylation of S100C/
A11 by TGF 1. Fig. S2 shows the effect of cycloheximide on autophos-
phorylation of PKC  by TGF 1. Fig. S3 shows the down-regulation of
Smad3 protein with siRNA. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200312041/DC1.
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